Scientists aim to develop universal vaccines protecting against all forms of a virus, tackling the high costs and challenges of current methods. Various technologies like mRNA and viral vectors are being explored. A recent US investment highlights the need for a broad, flexible approach to achieve success in universal vaccine development and global distribution.
